Paul Haber

1. Long‐Acting Injectable Buprenorphine in Prison: Insights From a Short‐Answer Survey of People in the Criminal Justice System Commencing Long‐Acting Injectable Buprenorphine During a Non‐Randomised Clinical Trial
   2026/08/03 by Amelia Woods, Catherine Foley, Adrian Dunlop +6 · 1 voice
   Medicine · #Opioid Use Disorder Treatment #HIV, Drug Use, Sexual Risk #Substance Abuse Treatment and Outcomes #Buprenorphine #Opioid use disorder #Thematic analysis #Clinical trial #Prison #Dosing #Economic Justice #Criminal justice
2. Models of care for the management of alcohol use disorder in general hospital settings and transition to the community: a scoping review
   2026/05/13 by Julia Sinclair, Sofia Hemrage, Nicola J. Kalk +7 · 1 voice
   Health Professions · Medicine · #Alcoholism and Thiamine Deficiency #Homelessness and Social Issues #Substance Abuse Treatment and Outcomes
3. Baclofen Modulates Neural Intrinsic Functional Connectivity in Treatment‐Seeking Individuals With Alcohol Use Disorder
   2026/06/01 by Warren Logge, Tristan Hurzeler, Paul Haber +3 · 1 voice
   Medicine · Neuroscience · #Functional Brain Connectivity Studies #Neurotransmitter Receptor Influence on Behavior #Substance Abuse Treatment and Outcomes
4. Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
   2026/02/01 by Lucy J. D. Peck, Bethany White, Maja Lindegaard Moensted +9 · 1 voice
   Medicine · #HIV, Drug Use, Sexual Risk #Opioid Use Disorder Treatment #Substance Abuse Treatment and Outcomes